Angiotensin 1/2 (1-6): Core Mechanisms in Cardiovascular & Renal Research

Executive Summary: Angiotensin 1/2 (1-6) (CAS: 47896-63-9) is a hexapeptide fragment derived from the N-terminus of angiotensin I and II, with the precise sequence Asp-Arg-Val-Tyr-Ile-His. It modulates vascular tone by inducing vasoconstriction and stimulating aldosterone release, thereby raising blood pressure and promoting sodium retention (Oliveira et al., 2025). The peptide is produced through proteolytic cleavage of liver-synthesized angiotensinogen by renin and angiotensin-converting enzymes in the renin-angiotensin system (RAS). Its high solubility in water (≥62.4 mg/mL) and DMSO (≥80.2 mg/mL), combined with 99.85% purity, make it ideal for cardiovascular and renal research workflows. Recent evidence also links angiotensin fragments, including (1-6), to modulation of viral spike protein binding, expanding its relevance to pathophysiological studies, including COVID-19 [DOI].

Biological Rationale

Angiotensin 1/2 (1-6) is a direct product of the enzymatic cleavage of angiotensinogen, a glycoprotein synthesized in the liver, by renin and ACE within the RAS (Oliveira et al., 2025). The RAS maintains cardiovascular and renal homeostasis by regulating systemic vascular resistance, blood pressure, and sodium-water balance. Angiotensin 1/2 (1-6) represents an N-terminal fragment of angiotensin I (1-10) and II (1-8), retaining the sequence Asp-Arg-Val-Tyr-Ile-His. This hexapeptide is central to studies dissecting the functional domains of angiotensin peptides and their specific receptor-mediated effects. Its activity has been implicated in both physiological regulation and disease processes, such as hypertension and acute viral pathogenesis.

Mechanism of Action of Angiotensin 1/2 (1-6)

Angiotensin 1/2 (1-6) acts primarily through modulation of vascular smooth muscle tone and stimulation of aldosterone secretion. This leads to vasoconstriction, increased blood pressure, and sodium retention (Oliveira et al., 2025). The hexapeptide binds to angiotensin II receptors, especially AT1R, triggering G protein-coupled signaling cascades that promote muscle contraction and hormone release. In addition, truncated angiotensin peptides, including the (1-6) fragment, have demonstrated enhanced activity in promoting spike–AXL binding, implicating a role in SARS-CoV-2 viral entry in cells with low ACE2 expression [DOI]. The precise sequence Asp-Arg-Val-Tyr-Ile-His allows for structure-function studies, including substitution or phosphorylation of specific residues to probe mechanism.

Evidence & Benchmarks

• Angiotensin 1/2 (1-6) increases spike–AXL binding in vitro similarly to angiotensin II, suggesting a facilitative role in viral pathogenesis (Oliveira et al., 2025).
• The peptide induces vasoconstriction and aldosterone release in isolated vascular and adrenal assays (Oliveira et al., 2025).
• High water solubility (≥62.4 mg/mL) and DMSO solubility (≥80.2 mg/mL) at 25°C enable robust in vitro and in vivo experimentation (APExBIO).
• Purity of 99.85% ensures reproducible readouts in cardiovascular regulation and renal function assays (APExBIO).
• The defined Asp-Arg-Val-Tyr-Ile-His sequence is optimal for mapping structure-activity relationships in RAS research (Angiotensin 1/2 (1-6): Mechanistic Tool for Cardiovascular Research).

This article extends previous mechanistic surveys by integrating new evidence on viral pathogenesis and benchmarking solubility/purity for translational workflows.

For further translational applications and a molecular perspective, see this in-depth analysis, which this article updates with the latest peer-reviewed viral interaction data.

Applications, Limits & Misconceptions

Angiotensin 1/2 (1-6) is used in:

• Renin-angiotensin system research: Dissecting the roles of peptide fragments in cardiovascular and renal physiology (Expanding the Frontiers of Renin-Angiotensin Research).
• Vascular tone modulation: Quantifying vasoconstriction and aldosterone stimulation for hypertension models (Oliveira et al., 2025).
• Viral pathogenesis studies: Probing how angiotensin fragments affect SARS-CoV-2 spike protein receptor binding (Oliveira et al., 2025).

Limits include:

• Not suitable as a direct clinical therapeutic; research use only (APExBIO).
• Results depend on model system, peptide modifications, and receptor expression context.

Common Pitfalls or Misconceptions

• Misconception: Angiotensin 1/2 (1-6) is a drug candidate—Fact: It is for research use only and not approved for clinical intervention.
• Misconception: Effects are identical to angiotensin II—Fact: The (1-6) fragment lacks C-terminal residues critical for full receptor spectrum activity (Oliveira et al., 2025).
• Misconception: Solubility in ethanol—Fact: Angiotensin 1/2 (1-6) is insoluble in ethanol, limiting certain preparation protocols (APExBIO).
• Misconception: Stable in solution at room temperature—Fact: Stock solutions must be stored at -20°C; short-term use recommended.
• Misconception: All angiotensin fragments affect spike–ACE2 equally—Fact: Only select fragments, including (1-6), enhance spike–AXL binding, not spike–ACE2 (Oliveira et al., 2025).

Workflow Integration & Parameters

APExBIO provides Angiotensin 1/2 (1-6) (A1048) as a high-purity solid for research use, with detailed preparation guidelines. Dissolve in water (≥62.4 mg/mL) or DMSO (≥80.2 mg/mL) at room temperature. Avoid ethanol as a solvent. Store aliquots at -20°C; thaw only as needed to preserve activity. For in vitro assays, typical concentrations range from 10 nM to 10 μM, depending on cell type and receptor density. For in vivo studies, consult published protocols and adjust dosing by species and physiological endpoint. The defined molecular weight (801.89 Da) allows precise molarity calculation. For method optimization, see the molecular insights review, which this article enhances by benchmarking purity and solubility for current experimental workflows.

Conclusion & Outlook

Angiotensin 1/2 (1-6) is a pivotal tool for dissecting angiotensin fragment function in vascular and renal biology. Its defined sequence, high purity, and solubility enable replicable research in cardiovascular regulation, hypertension models, and viral pathogenesis. Ongoing studies are elucidating its role in receptor-specific modulation and structure-activity relationships. For up-to-date product details, refer to the APExBIO Angiotensin 1/2 (1-6) product page. This overview clarifies operational boundaries and integrates new mechanistic insights, extending foundational research and informing future translational strategies.